Skip to main content
. 2014 Nov 1;5(18):8136–8146. doi: 10.18632/oncotarget.2357

Table 4. Overall response rate in 22 patients included in efficacy analysis.

Objective Response Rate Number of Patients, n (%)
Complete response 0
Partial response 4 (18)
Stable disease > 6 months 1 (4)
Stable disease < 6 months 9 (40)
Progressive disease 8 (36)